We initially treated OVCAR8 tumor‐bearing mice with a range of drug concentrations and found that CBP1 exhibited maximal tumor inhibition when administered at a dose of 10 mg/kg (Figure S7F, Supporting Information). This evidence concerns the gene SERPINH1 and neoplasm.